Business Context and Reporting Period
Company: Diebold Nixdorf, Inc.
Filing Type: Form 8-K (Current Report)
Date: October 20, 2022
Context: The Company entered into a Transaction Support Agreement with a group of creditors (Term Lender Group and Ad Hoc Group) to execute a recapitalization and new money financing transaction. This filing addresses near-term debt maturities and liquidity concerns.
Key Financial Metrics and Debt Structure
This filing details a proposed restructuring of the Company's capital structure rather than reporting standard operating results (revenue, profit, or cash flow) for a specific period. Key financial terms of the proposed transaction include:
- New ABL Facility: $250 million asset-based credit facility maturing in July 2026.
- Super Senior Facility: $400 million super-senior term loan for a German subsidiary, maturing in July 2025.
- Debt Exchange Participation:
- Existing Term Loans: ~78.8% of aggregate principal amount.
- 2024 Senior Notes: ~59.3% of aggregate principal amount.
- 2025 USD Senior Notes: ~91.8% of aggregate principal amount.
- 2025 EUR Senior Notes: ~85.4% of aggregate principal amount.
- Structuring Premium: Up to $12 million payable in cash to certain Initial Consenting Holders, calculated as 4% of the value of outstanding common shares.
Note: The filing text does not provide clear values for current revenue, net income, operating margins, or total liquidity balances as of the filing date.
Material Changes and Transaction Terms
The Transaction Support Agreement outlines significant changes to the Company's debt obligations:
- Term Loan Extension: Existing Term Loans will be exchanged for Extended Term Loans maturing in July 2025. A 15% prepayment of these loans is required on the closing date, with an additional 5% prepayment required by December 31, 2023 (or 2024 if liquidity thresholds are not met).
- 2024 Senior Notes Exchange: Holders may exchange notes at 95% of par for new secured "2L Notes" (maturing October 2026) and receive penny warrants representing 19.99% of outstanding common shares. Warrants are non-detachable and exercisable starting April 2024.
- Covenant Relief: The transaction seeks to remove substantially all negative covenants and mandatory prepayments from the 2024 Senior Notes and Existing Credit Agreement.
- Collateral Priority: The ABL Facility will hold first-priority liens on current assets. The Super Senior Facility and Extended Term Loans will hold first-priority liens on non-ABL collateral, ranking pari passu with 2025 Secured Notes.
Guidance, Risks, and Contingencies
Outlook and Conditions:
- Closing Conditions: The transaction is subject to definitive documentation, necessary consents, and minimum exchange thresholds. There is no assurance the transaction will close.
- Deadlines: If the transaction does not close by December 20, 2022, an in-kind ticking fee (100% of the SOFR margin) will accrue. The agreement terminates if not closed by December 31, 2022, unless extended.
- Projections: The Company shared internal projections regarding cash balances, free cash flow, and adjusted EBITDA with lenders (Exhibit 99.1), but these are not public guidance and are subject to significant uncertainty.
- Transaction Failure: Risk that the Company cannot secure sufficient creditor support or finalize documentation.
- Operational Risks: Global supply chain complexities, component shortages, and transport delays.
- Macro Factors: Impact of the COVID-19 pandemic, inflation, currency devaluations, and geopolitical conflicts (e.g., Russia-Ukraine).
- Cost Reduction: Reliance on achieving a $150 million+ cost savings plan.
- Legal: Outcomes of appraisal proceedings related to the merger with Diebold Nixdorf AG.
Investor Verification Checklist
- Verify the final closing date of the Transaction and whether the December 31, 2022 deadline was met.
- Confirm the total amount of debt successfully exchanged versus the initial consent percentages disclosed.
- Review the definitive terms of the new $250 million ABL Facility and $400 million Super Senior Facility.
- Assess the impact of the 19.99% warrant issuance on existing shareholder dilution.
- Monitor the Company's ability to meet the mandatory 15% and 5% prepayment requirements for Extended Term Loans.
- Check for updates on the $150 million cost-reduction initiative and its effect on liquidity.